Cargando…

Does angiogenesis matter in primary myelofibrosis?()

Detalles Bibliográficos
Autor principal: Campregher, Paulo Vidal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318378/
https://www.ncbi.nlm.nih.gov/pubmed/25305159
http://dx.doi.org/10.1016/j.bjhh.2014.07.009
_version_ 1782355840008716288
author Campregher, Paulo Vidal
author_facet Campregher, Paulo Vidal
author_sort Campregher, Paulo Vidal
collection PubMed
description
format Online
Article
Text
id pubmed-4318378
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Sociedade Brasileira de Hematologia e Hemoterapia
record_format MEDLINE/PubMed
spelling pubmed-43183782015-02-19 Does angiogenesis matter in primary myelofibrosis?() Campregher, Paulo Vidal Rev Bras Hematol Hemoter Scientific Comment Sociedade Brasileira de Hematologia e Hemoterapia 2014 2014-07-17 /pmc/articles/PMC4318378/ /pubmed/25305159 http://dx.doi.org/10.1016/j.bjhh.2014.07.009 Text en © 2014 Associac¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda. All rights. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Scientific Comment
Campregher, Paulo Vidal
Does angiogenesis matter in primary myelofibrosis?()
title Does angiogenesis matter in primary myelofibrosis?()
title_full Does angiogenesis matter in primary myelofibrosis?()
title_fullStr Does angiogenesis matter in primary myelofibrosis?()
title_full_unstemmed Does angiogenesis matter in primary myelofibrosis?()
title_short Does angiogenesis matter in primary myelofibrosis?()
title_sort does angiogenesis matter in primary myelofibrosis?()
topic Scientific Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318378/
https://www.ncbi.nlm.nih.gov/pubmed/25305159
http://dx.doi.org/10.1016/j.bjhh.2014.07.009
work_keys_str_mv AT campregherpaulovidal doesangiogenesismatterinprimarymyelofibrosis